SecBot SecBot
3 ·Filed Sep 21, 2026

RNAZ

Transcode Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001104659-26-109371
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

This is a routine initial ownership filing by a newly appointed officer with no current stake. Monitor for future Form 4 filings that may indicate insider buying or selling activity, which would provide a clearer signal on management's view of the company's prospects.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
RNAZ ▼ -5.08% at T+20d
NEUTRAL call -5.08% · α vs SPY -4.52% · entry $1.77 → $1.68
Next anchor: T+60d in 7w
Latest observation: T+23 +58.90% FF3 residual α
Entry = T+0 close
Sep 21, 2026
via day close
T+1d
-5.08%
call -5.08% · α -4.36%
$1.68
settled 5w ago
T+5d
-7.91%
call -7.91% · α -6.72%
$1.63
settled 4w ago
T+20d
-5.08%
call -5.08% · α -4.52%
$1.68
settled 9d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

John A. Tattory filed a Form 3 initial statement of beneficial ownership with the SEC, disclosing his role as Interim CFO of Transcode Therapeutics, Inc. The filing reports zero beneficial ownership of the company's securities and includes a limited power of attorney authorizing Philippe P. Calais to execute future Section 16 filings. This is a routine administrative filing with no material impact on the company's operations or stock.

Key Facts

  • John A. Tattory filed Form 3 as an officer (Interim CFO) of Transcode Therapeutics, Inc.
  • The filing reports zero shares beneficially owned by Tattory.
  • A limited power of attorney was granted to Philippe P. Calais for future Section 16 filings.
  • The filing date is September 21, 2026, with a period of report of September 10, 2026.

Financial Impact

No financial impact; the filing reports zero beneficial ownership of securities.

Risk Factors

  • No material risks identified from this filing.

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001104659-26-109371
Document: 0001104659-26-109371-index-headers.html0001104659-26-109371
Document: 0001104659-26-109371-index.html0001104659-26-109371
Document: 0001104659-26-109371.txt0001104659-26-109371
10 reports for RNAZ
Performance horizon
83% Hit rate @ T+20 5 of 6 directional calls Went positive at some point 6 of 6 best @ T+20▲ +70.83%Jun 3, 2026
Filters
Rows
Reports for RNAZ — sortable, filterable
TypeNow
Sep 28, 2026
29d ago
8-K
BULLISH ★ 6/10
$1.71 $1.71▼ −0.26%▼ −0.23%$1.67 (−2.34%)
Sep 21, 2026
5w ago
3
NEUTRAL ★ 2/10
$1.77 $1.68▼ −5.08%▼ −4.52%$1.67 (−5.65%)
Sep 11, 2026
6w ago
8-K
BEARISH ★ 5/10
$1.65 $1.63▲ +1.21%▲ +3.48%$1.67 (−1.21%)
Jul 2, 2026
16w ago
8-K
NEUTRAL ★ 3/10
$8.61 $4.22▼ −50.99%▼ −51.84%$1.67 (−80.60%)
Jun 18, 2026
18w ago
8-K
NEUTRAL ★ 4/10
$4.70 $8.27▲ +75.96%▲ +75.42%$1.67 (−64.47%)
Jun 3, 2026
20w ago
8-K
BULLISH ★ 6/10
$5.04 $8.61▲ +70.83%▲ +71.83%$1.67 (−66.87%)
May 26, 2026
22w ago
DEFA14A
BEARISH ★ 6/10
$5.39 $4.94▲ +8.35%▲ +6.40%$1.67 (+69.02%)
Apr 30, 2026
25w ago
S-3
BEARISH ★ 8/10
$7.83 $5.44▲ +30.59%▲ +35.85%$1.67 (+78.67%)
Apr 7, 2026
29w ago
8-K
BEARISH ★ 7/10
$8.70 $7.74▲ +11.03%▲ +20.82%$1.67 (+80.80%)
Mar 3, 2026
34w ago
DEFA14A
MIXED ★ 6/10
$9.84 $8.69▼ −11.69%▼ −7.27%$1.67 (−83.03%)
Showing 10 of 10

US Market Status

Market Closed — Opens Thu (11h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 21, 2026